抗精神病药物分类及用法一览表

2022-09-05 网络网络

临床必备

治疗分裂症药物：

用于治疗急慢性精神分裂症及其它精神病阳性症状（如幻觉、妄想、思维紊乱）和明显的阴性症状（如反应迟钝、情绪淡漠、孤僻少语）

利培酮（利培酮口崩片）	1mgX20片	治疗量2-3mg	bid	po
富马酸喹硫平（喹硫平）	100mgX60片	治疗量200mg	bid	po
氯丙嗪	50mgX100片	治疗量200-300mg	bid	po
奋乃静	4mgX100片	治疗量8-12mg	bid	po
氯氮平	25mgX100片	治疗量50-100mg	bid	po
舒必利	100mgX100片	治疗量100-300mg	bid	po
奥氮平	10mgX7片	治疗量10-20mg	qd	po

长效药物：五氟利多片 20mgX24片，20mg-40mg每周一次

抗躁狂药物（情绪稳定剂）

用于治疗躁狂症，和躁狂抑郁交替发作的双相情感性精神障碍，对反复发作抑郁症也有预防作用。（因碳酸锂不用，以下5种药物实际为抗癫痫药，用其抗躁狂）

丙戊酸钠	100mg X100片	治疗量100mg-200mg	bid	po
卡马西平	100mg X100片	治疗量100mg-200mg	bid	po
奥卡西平	150mg X50片	治疗量300-1200mg	bid	po
拉莫三嗪(利必通)	50mg X30片	治疗量25-50mg	qd	po
丙戊酸钠缓释片(德巴金)	500mg X30片	治疗量250-750mg	qd	po

抗焦虑抗抑郁药物：

舍曲林（盐酸舍曲林） 50mgX14片 50-100mg 晚上服一日一次

帕罗西汀（盐酸帕罗西汀） 20mgX14片 20-40mg 晚上服一日一次

小剂量抗焦虑，大剂量治疗失眠药物：

地西泮（安定）	2.5mg X100片	治疗量2.5-10mg	bid	po
	（焦虑2.5-10 mg,2-4次,镇静2.5-5 mg tid,催眠5-10 mg qn,极量4-40 mg）
氯硝西泮（氯硝安定）	2mgX100片	治疗量2-4mg	bid	po
劳拉西泮	1mgX28片	治疗量1-3mg	bid	po
阿普唑仑	0.4mgX100片	治疗量0.4-0.8mg	bid	po
艾司唑仑（舒乐安定）	1mgX100片	治疗量1-3mg	bid	po

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2153903, encodeId=6a0c2153903ab, content=很详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db498817484, createdName=ms4000000301371148, createdTime=Mon Aug 21 18:26:08 CST 2023, time=2023-08-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1248585, encodeId=2b86124858594, content=受教育了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:22:04 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248584, encodeId=7d9a124858492, content=很左冇有1冂月月用, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:18:39 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247818, encodeId=794f124e818c0, content=简洁明了，系统学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05155126416, createdName=146480bem82暂无昵称, createdTime=Thu Sep 08 07:22:01 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513121, encodeId=0fad15131211d, content=<a href='/topic/show?id=bdc555596cd' target=_blank style='color:#2F92EE;'>#抗精神病药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55596, encryptionId=bdc555596cd, topicName=抗精神病药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=694d10531994, createdName=12498768m16(暂无昵称), createdTime=Wed Sep 07 05:50:38 CST 2022, time=2022-09-07, status=1, ipAttribution=)]
2023-08-21 ms4000000301371148 来自新疆

很详细

55 0
[GetPortalCommentsPageByObjectIdResponse(id=2153903, encodeId=6a0c2153903ab, content=很详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db498817484, createdName=ms4000000301371148, createdTime=Mon Aug 21 18:26:08 CST 2023, time=2023-08-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1248585, encodeId=2b86124858594, content=受教育了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:22:04 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248584, encodeId=7d9a124858492, content=很左冇有1冂月月用, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:18:39 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247818, encodeId=794f124e818c0, content=简洁明了，系统学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05155126416, createdName=146480bem82暂无昵称, createdTime=Thu Sep 08 07:22:01 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513121, encodeId=0fad15131211d, content=<a href='/topic/show?id=bdc555596cd' target=_blank style='color:#2F92EE;'>#抗精神病药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55596, encryptionId=bdc555596cd, topicName=抗精神病药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=694d10531994, createdName=12498768m16(暂无昵称), createdTime=Wed Sep 07 05:50:38 CST 2022, time=2022-09-07, status=1, ipAttribution=)]
2022-09-13 ms6000000225486324

受教育了

59 0
[GetPortalCommentsPageByObjectIdResponse(id=2153903, encodeId=6a0c2153903ab, content=很详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db498817484, createdName=ms4000000301371148, createdTime=Mon Aug 21 18:26:08 CST 2023, time=2023-08-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1248585, encodeId=2b86124858594, content=受教育了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:22:04 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248584, encodeId=7d9a124858492, content=很左冇有1冂月月用, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:18:39 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247818, encodeId=794f124e818c0, content=简洁明了，系统学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05155126416, createdName=146480bem82暂无昵称, createdTime=Thu Sep 08 07:22:01 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513121, encodeId=0fad15131211d, content=<a href='/topic/show?id=bdc555596cd' target=_blank style='color:#2F92EE;'>#抗精神病药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55596, encryptionId=bdc555596cd, topicName=抗精神病药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=694d10531994, createdName=12498768m16(暂无昵称), createdTime=Wed Sep 07 05:50:38 CST 2022, time=2022-09-07, status=1, ipAttribution=)]
2022-09-13 ms6000000225486324

很左冇有1冂月月用

49 0
[GetPortalCommentsPageByObjectIdResponse(id=2153903, encodeId=6a0c2153903ab, content=很详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db498817484, createdName=ms4000000301371148, createdTime=Mon Aug 21 18:26:08 CST 2023, time=2023-08-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1248585, encodeId=2b86124858594, content=受教育了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:22:04 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248584, encodeId=7d9a124858492, content=很左冇有1冂月月用, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:18:39 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247818, encodeId=794f124e818c0, content=简洁明了，系统学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05155126416, createdName=146480bem82暂无昵称, createdTime=Thu Sep 08 07:22:01 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513121, encodeId=0fad15131211d, content=<a href='/topic/show?id=bdc555596cd' target=_blank style='color:#2F92EE;'>#抗精神病药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55596, encryptionId=bdc555596cd, topicName=抗精神病药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=694d10531994, createdName=12498768m16(暂无昵称), createdTime=Wed Sep 07 05:50:38 CST 2022, time=2022-09-07, status=1, ipAttribution=)]
2022-09-08 146480bem82暂无昵称

简洁明了，系统学习

86 0
[GetPortalCommentsPageByObjectIdResponse(id=2153903, encodeId=6a0c2153903ab, content=很详细, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db498817484, createdName=ms4000000301371148, createdTime=Mon Aug 21 18:26:08 CST 2023, time=2023-08-21, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1248585, encodeId=2b86124858594, content=受教育了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:22:04 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248584, encodeId=7d9a124858492, content=很左冇有1冂月月用, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Tue Sep 13 07:18:39 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247818, encodeId=794f124e818c0, content=简洁明了，系统学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05155126416, createdName=146480bem82暂无昵称, createdTime=Thu Sep 08 07:22:01 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513121, encodeId=0fad15131211d, content=<a href='/topic/show?id=bdc555596cd' target=_blank style='color:#2F92EE;'>#抗精神病药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55596, encryptionId=bdc555596cd, topicName=抗精神病药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=694d10531994, createdName=12498768m16(暂无昵称), createdTime=Wed Sep 07 05:50:38 CST 2022, time=2022-09-07, status=1, ipAttribution=)]
2022-09-07 12498768m16(暂无昵称)

#抗精神病药#

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

精神心理

抗精神病药物分类及用法一览表

相关资讯

科室

工具

服务